Special enema device for patients with hepatic encephalopathy

Abstract

The utility model is applicable to the technical field of hepatic encephalopathy treatment, and discloses a special enema device for hepatic encephalopathy patients, which is characterized in that the bottom of a medicament storage bag is fixedly communicated with a connecting hose, the bottom of the connecting hose is fixedly communicated with a dropper, the bottom of the dropper is fixedly communicated with an infusion hose, and the side edge of the medicament storage bag is transversely and fixedly communicated with a liquid inlet pipe; the end, away from the medicament storage bag, of the liquid inlet pipe is fixedly communicated with a measuring cup, a flow limiting pipe clamp is movably connected to the outer side surface of the liquid inlet pipe in an inserted mode, the outer side surface of the infusion hose is fixedly sleeved with a flow speed controller, and a plurality of sets of liquid outlets are formed in the two ends of the side edge of the bottom of the infusion hose. According to the technical scheme, the measuring cup and the medicine storage bag are communicated through the clamping and flow limiting effects of the limiting pipe clamp and the liquid inlet pipe, the injection amount of enema medicine can be accurately controlled and processed, the device is easy to operate, and small-dose medicine can be measured through the measuring cup to ensure that the dosage of the medicine is accurate.

Description

Technical Field

[0001] The utility model is applicable to the technical field of hepatic encephalopathy treatment, and particularly relates to a special enema device for hepatic encephalopathy patients. Background Art

[0002] At present, hepatic encephalopathy (HE) is one of the serious complications of patients with decompensated cirrhosis. The incidence of hepatic encephalopathy in patients with cirrhosis abroad is 30%-45%, and the incidence of hepatic encephalopathy in my country is 10%-50%. Once hepatic encephalopathy occurs, the 1-year survival rate is less than 50%, and the 3-year survival rate is less than 25%. The ammonia poisoning theory is the most important mechanism of its pathogenesis. Lowering blood ammonia concentration is the primary principle of current treatment of hepatic encephalopathy. The toxic substances that cause hepatic encephalopathy mainly come from the intestines. About 50% of ammonia is produced by colon bacteria. Therefore, cleaning the intestines is a fast and effective way to reduce the production and absorption of ammonia and other toxic substances. It is very important in the prevention and treatment of hepatic encephalopathy. Drug retention enema is a clinical Commonly used treatment methods in the clinic can clear intestinal food accumulation, blood accumulation and other nitrogen-containing substances. Factors that affect the efficacy of HE retention enema, in addition to the quality and quantity of retention enema solution, the selection of retention enema instruments, changes in body position and insertion depth, and the temperature of retention enema solution are all important factors that affect the effect of retention enema. Commonly used and recognized enema solutions in clinical practice include rhubarb, lactulose, and vinegar. Rhubarb can inhibit the transport of sodium from the intestinal wall to cells, promote water retention in the intestinal cavity, expand the intestine, stimulate the intestinal wall, and promote defecation; it can reduce the degeneration and necrosis of liver cells and reduce the increase in blood ammonia; it can reduce cell respiration and the synthesis of nucleic acids and nucleoproteins; it can reduce the formation of antibodies and immune complexes, and reduce the damage to liver cells. Use 9-12g of raw rhubarb powder, 60ml of vinegar and 90ml of warm water to mix well and retain enema. It is safe, effective, economical and practical to treat hepatic encephalopathy. It is a synthetic disaccharide that is not absorbed in the small intestine. It is mainly decomposed and metabolized into lactic acid and a small amount of acetic acid by lactobacillus, anaerobic bacteria, Escherichia coli, etc. in the right colon, which reduces the intestinal pH value to below 6, thereby inhibiting the production of ammonia by intestinal bacteria and combining the existing NH3 in the intestinal cavity with H+ to form unabsorbed NH4+ and excreted from the body with feces. Lactulose can form a hypertonic state in the intestine, increase intestinal contents, increase the frequency of bowel movements, thereby reducing the accumulation of toxins and protecting the intestinal mucosal barrier. In liver protection treatment, 20-30ml of lactulose oral solution is used for retention enema. 2 times / d; it has a good therapeutic effect on improving liver function. Vinegar contains acetic acid, lactic acid and organic acid. On the one hand, it stimulates intestinal peristalsis and removes nitrogenous substances in the intestine; on the other hand, it keeps the intestinal pH value below 5-6 in a weakly acidic environment, which is conducive to the escape of blood ammonia from the intestinal cavity and excretion with feces, thereby reducing blood ammonia. On the basis of conventional treatment, 150ml of 20% vinegar is used for retention enema, which plays a role in protecting the liver and improves the survival rate of patients. The treatment is safe and effective. Due to the low price of vinegar, it is widely used in hospitals at all levels, especially grassroots hospitals. The existing disposable enema bags have too large scales and cannot be accurately administered. There are many inconveniences when applying specific treatments to patients, which adds unnecessary trouble to this operation. Therefore, we propose a special enema device for patients with hepatic encephalopathy. Utility Model Content

[0003] The main purpose of the utility model is to provide a special enema device for patients with hepatic encephalopathy, which can effectively solve the problems in the background technology.

[0004] In order to achieve the above purpose, the technical solution adopted by the utility model is:

[0005] A special enema device for patients with hepatic encephalopathy comprises a medicine storage bag, the bottom of the medicine storage bag is fixedly connected to a connecting hose, the bottom of the connecting hose is fixedly connected to a dropper, the bottom of the dropper is fixedly connected to an infusion hose, the side of the medicine storage bag is laterally fixedly connected to a liquid inlet pipe, one end of the liquid inlet pipe away from the medicine storage bag is fixedly connected to a measuring cup, and the outer surface of the liquid inlet pipe is movably connected with a flow limiting pipe clamp.

[0006] By adopting the above technical solution, the amount of enema medicine injected can be accurately controlled through the clamping and limiting flow of the limiting tube clamp and the connection of the measuring cup with the medicine storage bag in combination with the liquid inlet tube. The device is easy to operate and a small dose of medicine can be measured through the measuring cup to ensure the accuracy of the medicine dosage.

[0007] As an optional solution of the technical solution of the present application, a flow rate controller is fixedly sleeved on the outer surface of the infusion hose.

[0008] By adopting the above technical solution and combining it with the structure of the flow rate controller, the speed of the enema liquid dripping can be controlled.

[0009] As an optional solution of the technical solution of the present application, both ends of the bottom side of the infusion hose are provided with drainage ports, and the number of the drainage ports is several groups.

[0010] By adopting the above technical solution, the enema medicine is non-irritating to the mucosa during delivery due to the structural effect of the liquid discharge port, so that the patient feels comfortable during the enema process without pain or discomfort.

[0011] Compared with the prior art, the utility model has the following beneficial effects:

[0012] The enema device for hepatic encephalopathy patients of the technical solution of the present application is provided with a measuring cup on the side of the medicine storage bag through a liquid inlet pipe, and the clamping and limiting effect of the liquid inlet pipe by the flow limiting pipe clamp can enable medical workers to pour the enema medicine to be injected into the measuring cup in advance, and then accurately control the injection amount of the enema medicine in combination with the scale lines on the outer side of the measuring cup. The device is easy to operate, and a small dose of medicine can be measured by the measuring cup to ensure the accuracy of the medicine dosage;

[0013] By opening drainage ports on both sides of the bottom of the infusion hose for drug delivery, it is beneficial for the drug to fully contact the intestinal wall and promote drug absorption. In addition, combined with a flow rate controller, it can be used during enema to adjust the drug flow rate and infuse the drug at a uniform speed, so that the patient can retain the drug for a long time, increase its efficacy and relieve the patient's pain. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] Figure 1 This is a schematic diagram of the overall front view structure of a special enema device for patients with hepatic encephalopathy according to the utility model;

[0015] Figure 2 The utility model is a schematic diagram of the side cross-sectional structure of the bottom end of an infusion hose of a special enema device for patients with hepatic encephalopathy.

[0016] Figure numerals: 1. medicine storage bag; 11. connecting hose; 12. dropper; 13. infusion hose; 14. flow rate controller; 15. discharge port; 2. liquid inlet pipe; 21. measuring cup; 3. flow limiting tube clamp. DETAILED DESCRIPTION

[0017] like Figure 1-2 As shown, the utility model provides a technical solution: an enema device specially used for patients with hepatic encephalopathy, wherein the outer surface of the liquid inlet tube 2 is movably connected with a flow limiting tube clamp 3, the side of the medicine storage bag 1 is laterally fixedly connected with the liquid inlet tube 2, and the end of the liquid inlet tube 2 away from the medicine storage bag 1 is fixedly connected with a measuring cup 21.

[0018] In this technical solution (through Figure 1 and Figure 2 As shown), the bottom of the medicine storage bag 1 is fixedly connected to a connecting hose 11, the bottom of the connecting hose 11 is fixedly connected to a dropper 12, the bottom of the dropper 12 is fixedly connected to an infusion hose 13, and the outer side of the infusion hose 13 is provided with 5cm, 10cm, 15cm, and 20cm scale lines.

[0019] In this technical solution (through Figure 1 and Figure 2 As shown), a flow rate controller 14 is fixedly sleeved on the outer surface of the infusion hose 13.

[0020] In this technical solution (through Figure 1 and Figure 2 As shown), both ends of the bottom side of the infusion hose 13 are provided with drainage ports 15, and the number of the drainage ports 15 is several groups.

[0021] During operation, when enema treatment is required for patients with hepatic encephalopathy, firstly, the outer side of the liquid inlet tube 2 connected between the measuring cup 21 and the medicine storage bag is clamped with the flow limiting tube clamp 3 to limit the flow, and then the medicine is poured into the measuring cup 21 to select the required medicine volume, and then the flow limiting tube clamp 3 is pulled out to separate it from the outer side of the liquid inlet tube 2, and then the inside of the measuring cup 21 is allowed to flow into the medicine storage bag 1, and the medicine storage bag 1 is hung on the infusion stand, and then the air is exhausted according to the intravenous infusion exhaust method, and the medicine storage bag is filled with the medicine. 1, the liquid level is no more than 30cm away from the anus, and then the anus and the front end of the infusion hose 13 are lubricated with liquid paraffin, and the infusion hose 13 is placed into the intestine to be enema through the anus. Because it is a retention enema, and combined with multiple groups of scale lines arranged on the outer side of the bottom of the infusion hose 13, the anal canal is placed 10 to 15cm into the intestine. During the enema process, a flow rate regulator is used to control the flow rate of the liquid medicine inside the infusion hose 13 to achieve the purpose of retention enema, so that the patient feels comfortable during the enema process without pain or discomfort.

Claims

1. A special enema device for patients with hepatic encephalopathy, comprising a medicine storage bag (1), characterized in that: The bottom of the medicine storage bag (1) is fixedly connected to a connecting hose (11), the bottom of the connecting hose (11) is fixedly connected to a dropper (12), and the bottom of the dropper (12) is fixedly connected to an infusion hose (13); A liquid inlet pipe (2) is fixedly connected to the side of the medicine storage bag (1) in a transverse direction, and a measuring cup (21) is fixedly connected to one end of the liquid inlet pipe (2) away from the medicine storage bag (1); The outer surface of the liquid inlet pipe (2) is movably connected with a flow limiting pipe clamp (3).

2. The enema device for hepatic encephalopathy patients according to claim 1, characterized in that: A flow rate controller (14) is fixedly sleeved on the outer surface of the infusion hose (13).

3. The enema device for hepatic encephalopathy patients according to claim 1, characterized in that: Both ends of the bottom side of the infusion hose (13) are provided with drainage ports (15), and the number of the drainage ports (15) is several groups.

Images